
### [MONDO:0020124](http://purl.obolibrary.org/obo/MONDO_0020124)
**Label:** neuromuscular junction disease

**Subclasses:** [MONDO:0014585](http://purl.obolibrary.org/obo/MONDO_0014585) (congenital myasthenic syndrome 3C), [MONDO:0014586](http://purl.obolibrary.org/obo/MONDO_0014586) (congenital myasthenic syndrome 4B), [MONDO:0014542](http://purl.obolibrary.org/obo/MONDO_0014542) (congenital myasthenic syndrome 15), [MONDO:0014587](http://purl.obolibrary.org/obo/MONDO_0014587) (congenital myasthenic syndrome 9), [MONDO:0014983](http://purl.obolibrary.org/obo/MONDO_0014983) (congenital myasthenic syndrome 21), [MONDO:0018743](http://purl.obolibrary.org/obo/MONDO_0018743) (immune-mediated acquired neuromuscular junction disease), [MONDO:0014543](http://purl.obolibrary.org/obo/MONDO_0014543) (congenital myasthenic syndrome 14), [MONDO:0014588](http://purl.obolibrary.org/obo/MONDO_0014588) (congenital myasthenic syndrome 11), [MONDO:0014581](http://purl.obolibrary.org/obo/MONDO_0014581) (congenital myasthenic syndrome 2A), [MONDO:0018940](http://purl.obolibrary.org/obo/MONDO_0018940) (congenital myasthenic syndrome), [MONDO:0014582](http://purl.obolibrary.org/obo/MONDO_0014582) (congenital myasthenic syndrome 2C), [MONDO:0014583](http://purl.obolibrary.org/obo/MONDO_0014583) (congenital myasthenic syndrome 3A), [MONDO:0014584](http://purl.obolibrary.org/obo/MONDO_0014584) (congenital myasthenic syndrome 3B), [MONDO:0018144](http://purl.obolibrary.org/obo/MONDO_0018144) (congenital myasthenic syndromes with glycosylation defect), [MONDO:0020344](http://purl.obolibrary.org/obo/MONDO_0020344) (postsynaptic congenital myasthenic syndromes), [MONDO:0020345](http://purl.obolibrary.org/obo/MONDO_0020345) (presynaptic congenital myasthenic syndromes), [MONDO:0020346](http://purl.obolibrary.org/obo/MONDO_0020346) (synaptic congenital myasthenic syndromes), [MONDO:0014468](http://purl.obolibrary.org/obo/MONDO_0014468) (congenital myasthenic syndrome 7), [MONDO:0014745](http://purl.obolibrary.org/obo/MONDO_0014745) (congenital myasthenic syndrome 19), [MONDO:0013883](http://purl.obolibrary.org/obo/MONDO_0013883) (congenital myasthenic syndrome 13), [MONDO:0012157](http://purl.obolibrary.org/obo/MONDO_0012157) (congenital myasthenic syndrome 4C), [MONDO:0012156](http://purl.obolibrary.org/obo/MONDO_0012156) (congenital myasthenic syndrome 1B), [MONDO:0014052](http://purl.obolibrary.org/obo/MONDO_0014052) (congenital myasthenic syndrome 8), [MONDO:0012518](http://purl.obolibrary.org/obo/MONDO_0012518) (congenital myasthenic syndrome 12), [MONDO:0014939](http://purl.obolibrary.org/obo/MONDO_0014939) (congenital myasthenic syndrome 20), [MONDO:0014578](http://purl.obolibrary.org/obo/MONDO_0014578) (congenital myasthenic syndrome 17), [MONDO:0009690](http://purl.obolibrary.org/obo/MONDO_0009690) (congenital myasthenic syndrome 10), [MONDO:0018325](http://purl.obolibrary.org/obo/MONDO_0018325) (juvenile myasthenia gravis), [MONDO:0018326](http://purl.obolibrary.org/obo/MONDO_0018326) (transient neonatal myasthenia gravis), [MONDO:0016468](http://purl.obolibrary.org/obo/MONDO_0016468) (toxin-mediated infectious botulism), [MONDO:0016100](http://purl.obolibrary.org/obo/MONDO_0016100) (rippling muscle disease with myasthenia gravis), [MONDO:0018324](http://purl.obolibrary.org/obo/MONDO_0018324) (adult-onset myasthenia gravis), [MONDO:0020125](http://purl.obolibrary.org/obo/MONDO_0020125) (acquired neuromuscular junction disease), [MONDO:0016777](http://purl.obolibrary.org/obo/MONDO_0016777) (Inhalational botulism), [MONDO:0018556](http://purl.obolibrary.org/obo/MONDO_0018556) (Lambert-Eaton myasthenic syndrome), [MONDO:0011281](http://purl.obolibrary.org/obo/MONDO_0011281) (congenital myasthenic syndrome 5), [MONDO:0013620](http://purl.obolibrary.org/obo/MONDO_0013620) (congenital myasthenic syndrome 16), [MONDO:0011088](http://purl.obolibrary.org/obo/MONDO_0011088) (congenital myasthenic syndrome 1A), [MONDO:0016453](http://purl.obolibrary.org/obo/MONDO_0016453) (foodborne botulism), [MONDO:0008036](http://purl.obolibrary.org/obo/MONDO_0008036) (myasthenia, limb-girdle, autoimmune), [MONDO:0009687](http://purl.obolibrary.org/obo/MONDO_0009687) (myasthenia, congenital, refractory to acetylcholinesterase Inhibitors), [MONDO:0009688](http://purl.obolibrary.org/obo/MONDO_0009688) (myasthenia gravis), [MONDO:0014590](http://purl.obolibrary.org/obo/MONDO_0014590) (congenital myasthenic syndrome 18), [MONDO:0009689](http://purl.obolibrary.org/obo/MONDO_0009689) (congenital myasthenic syndrome 6), [MONDO:0005498](http://purl.obolibrary.org/obo/MONDO_0005498) (botulism), [MONDO:0015804](http://purl.obolibrary.org/obo/MONDO_0015804) (infant botulism), [MONDO:0011600](http://purl.obolibrary.org/obo/MONDO_0011600) (congenital myasthenic syndrome 4A), [MONDO:0015803](http://purl.obolibrary.org/obo/MONDO_0015803) (wound botulism), [MONDO:0015806](http://purl.obolibrary.org/obo/MONDO_0015806) (adult intestinal botulism), [MONDO:0015805](http://purl.obolibrary.org/obo/MONDO_0015805) (intestinal botulism), [MONDO:0016778](http://purl.obolibrary.org/obo/MONDO_0016778) (Iatrogenic botulism), [MONDO:0011768](http://purl.obolibrary.org/obo/MONDO_0011768) (myasthenia gravis with thymus hyperplasia), 

**Corr. equiv. classes:** [Orphanet:228371](http://www.orpha.net/ORDO/Orphanet_228371), [Orphanet:391497](http://www.orpha.net/ORDO/Orphanet_391497), [Orphanet:43393](http://www.orpha.net/ORDO/Orphanet_43393), [Orphanet:391490](http://www.orpha.net/ORDO/Orphanet_391490), [Orphanet:254504](http://www.orpha.net/ORDO/Orphanet_254504), [OMIM:614198](http://purl.obolibrary.org/obo/OMIM_614198), [OMIM:616330](http://purl.obolibrary.org/obo/OMIM_616330), [OMIM:615120](http://purl.obolibrary.org/obo/OMIM_615120), [OMIM:617143](http://purl.obolibrary.org/obo/OMIM_617143), [OMIM:614750](http://purl.obolibrary.org/obo/OMIM_614750), [OMIM:254300](http://purl.obolibrary.org/obo/OMIM_254300), [Orphanet:464764](http://www.orpha.net/ORDO/Orphanet_464764), [Orphanet:98494](http://www.orpha.net/ORDO/Orphanet_98494), [OMIM:601462](http://purl.obolibrary.org/obo/OMIM_601462), [Orphanet:206575](http://www.orpha.net/ORDO/Orphanet_206575), [Orphanet:590](http://www.orpha.net/ORDO/Orphanet_590), [OMIM:608930](http://purl.obolibrary.org/obo/OMIM_608930), [OMIM:608931](http://purl.obolibrary.org/obo/OMIM_608931), [Orphanet:178478](http://www.orpha.net/ORDO/Orphanet_178478), [Orphanet:178475](http://www.orpha.net/ORDO/Orphanet_178475), [OMIM:616228](http://purl.obolibrary.org/obo/OMIM_616228), [OMIM:616304](http://purl.obolibrary.org/obo/OMIM_616304), [OMIM:617239](http://purl.obolibrary.org/obo/OMIM_617239), [OMIM:616227](http://purl.obolibrary.org/obo/OMIM_616227), [OMIM:607085](http://purl.obolibrary.org/obo/OMIM_607085), [Orphanet:589](http://www.orpha.net/ORDO/Orphanet_589), [OMIM:254210](http://purl.obolibrary.org/obo/OMIM_254210), [OMIM:603034](http://purl.obolibrary.org/obo/OMIM_603034), [OMIM:159400](http://purl.obolibrary.org/obo/OMIM_159400), [Orphanet:178487](http://www.orpha.net/ORDO/Orphanet_178487), [OMIM:616314](http://purl.obolibrary.org/obo/OMIM_616314), [OMIM:616313](http://purl.obolibrary.org/obo/OMIM_616313), [Orphanet:98913](http://www.orpha.net/ORDO/Orphanet_98913), [Orphanet:178481](http://www.orpha.net/ORDO/Orphanet_178481), [Orphanet:98914](http://www.orpha.net/ORDO/Orphanet_98914), [Orphanet:98915](http://www.orpha.net/ORDO/Orphanet_98915), [Orphanet:353327](http://www.orpha.net/ORDO/Orphanet_353327), [OMIM:254200](http://purl.obolibrary.org/obo/OMIM_254200), [Orphanet:391504](http://www.orpha.net/ORDO/Orphanet_391504), [OMIM:254190](http://purl.obolibrary.org/obo/OMIM_254190), [OMIM:616040](http://purl.obolibrary.org/obo/OMIM_616040), [OMIM:605809](http://purl.obolibrary.org/obo/OMIM_605809), [OMIM:616321](http://purl.obolibrary.org/obo/OMIM_616321), [Orphanet:230800](http://www.orpha.net/ORDO/Orphanet_230800), [OMIM:616325](http://purl.obolibrary.org/obo/OMIM_616325), [Orphanet:254509](http://www.orpha.net/ORDO/Orphanet_254509), [OMIM:616324](http://purl.obolibrary.org/obo/OMIM_616324), [OMIM:616720](http://purl.obolibrary.org/obo/OMIM_616720), [Orphanet:1267](http://www.orpha.net/ORDO/Orphanet_1267), [OMIM:616323](http://purl.obolibrary.org/obo/OMIM_616323), [OMIM:616322](http://purl.obolibrary.org/obo/OMIM_616322), [OMIM:610542](http://purl.obolibrary.org/obo/OMIM_610542), [OMIM:616326](http://purl.obolibrary.org/obo/OMIM_616326), 

**Class expressions from DL-Learner:**

- [HP:0000508](http://purl.obolibrary.org/obo/HP_0000508) (Ptosis) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) 58.58%
- [HP:0000508](http://purl.obolibrary.org/obo/HP_0000508) (Ptosis) and [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) 55.04%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 55.04%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) 55.04%
- [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 52.22%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) 52.22%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) 52.13%
- [HP:0003388](http://purl.obolibrary.org/obo/HP_0003388) (Easy fatigability) 48.93%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 43.11%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 42.36%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 40.05%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 39.98%
- Thing 39.96%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 39.96%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 37.80%


